Chakshu研究

查爾斯頓實驗室,公司是一個專業製藥公司專注於疼痛產品的研究和開發,避免或大大減少惡心和嘔吐,兩個最繁重的副作用與阿片類止痛藥和其他疼痛相關的疾病。

Indena是一家致力於識別、開發和生產的活動原則來源於植物,用於製藥、保健食品和化妝品行業。Indena、民營意大利公司約有700名員工,其中包括10%致力於全職研究,旨在培養管理,製造、分銷業務在全世界40多個國家。Indena成功的關鍵是它的研究,包括:藥用植物的藥理篩選的好處;識別新的活躍的原則;提取和純化係統的開發和工業應用的前沿。phyto-chemical研究進行Indena Settala自己的研究中心,意大利。Indena同樣也與世界上最著名的大學和私人研究機構在生物的安全性和有效性臨床評估階段i的主要戰略目標之一的醫藥研究開發新的積極的原則的應用程序。這也是一個不可缺少的保健食品和化妝品行業的基礎。在製藥行業Indena目前專注於抗癌治療的發展,紫杉醇的成功後,以及在抗菌和抗病毒藥物。還在研究是活躍的原則治療病態和中樞神經係統功能障礙,如抑鬱,焦慮,陽痿,睡眠障礙、感覺過敏。 Today Indena is also concentrating its efforts on the industrial production of high-quality standardised active principles derived from plants, which are important ingredients in health food products. In fact, the company produces standardised extracts from edible plants that are traditionally recognised as having therapeutic properties, as well as from plants that have proven pharmacological value. Indena's research and production activities are particularly attentive to plant-based principles that have anti-oxidant properties and are effective in preventing damage caused by free radicals. Backed by over 80 years of botanical experience, the Italian company has developed a plantation network, managed by experts, to supply its research and production centers with officinal plants, while at the same time ensuring bio-diversity and protecting the ecosystem balance from uncontrolled harvesting. Today more than 60% of the raw material used in the manufacturing process comes from cultivation. Indena's decades-long global presence in the plant extraction industry is a guarantee of its in-depth knowledge and understanding of the business, market trends and legal considerations, through constant communication and interaction between the company's experts and the major international regulatory authorities such as WHO, EMEA, and ESCOP, and main pharmacopoeias.

選擇研究伯明翰公司管理的臨床開發試驗。

Inverseon概述有超過2000萬的美國人患有哮喘,數量繼續增加。Inverseon, inc .是一家臨床分期開發藥物肺部的慢性疾病。Inverseon哮喘項目活動花絮概念驗證人類研究已經成功地完成了兩個階段

寵物Medicus實驗室是一個從事的專業製藥公司製定、臨床試驗、聯邦注冊、生產、和銷售藥品的寵物市場。

科茲摩是一個基礎的專業製藥公司,旨在成為從事市場選擇的優化治療胃腸疾病。公司的臨床開發管道具體地址治療炎症性腸病(IBD),如潰瘍性結腸炎、克羅恩病、結腸和感染。